Tandem Diabetes Care Inc (NASDAQ: TNDM) on Tuesday, plunged -1.25% from the previous trading day, before settling in for the closing price of $30.42. Within the past 52 weeks, TNDM’s price has moved between $18.45 and $53.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 36.59% over the past five years. The company achieved an average annual earnings per share of 50.64%. With a float of $65.14 million, this company’s outstanding shares have now reached $65.55 million.
Let’s look at the performance matrix of the company that is accounted for 2400 employees. In terms of profitability, gross margin is 43.69%, operating margin of -13.72%, and the pretax margin is -12.65%.
Tandem Diabetes Care Inc (TNDM) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Tandem Diabetes Care Inc is 0.81%, while institutional ownership is 112.73%. The most recent insider transaction that took place on Nov 21 ’24, was worth 941,400. In this transaction Director of this company sold 30,000 shares at a rate of $31.38, taking the stock ownership to the 165,190 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Director sold 10,000 for $30.00, making the entire transaction worth $300,000. This insider now owns 195,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 50.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.00% during the next five years compared to -6.11% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Tandem Diabetes Care Inc (TNDM) is currently performing well based on its current performance indicators. A quick ratio of 2.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.94, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.21 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Inc (NASDAQ: TNDM) saw its 5-day average volume 1.56 million, a negative change from its year-to-date volume of 1.6 million. As of the previous 9 days, the stock’s Stochastic %D was 62.59%. Additionally, its Average True Range was 1.80.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 13.70%, which indicates a significant decrease from 39.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.75% in the past 14 days, which was higher than the 63.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.65, while its 200-day Moving Average is $38.22. Nevertheless, the first resistance level for the watch stands at $30.74 in the near term. At $31.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.82. If the price goes on to break the first support level at $29.66, it is likely to go to the next support level at $29.29. Assuming the price breaks the second support level, the third support level stands at $28.58.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
Market capitalization of the company is 1.97 billion based on 65,677K outstanding shares. Right now, sales total 747,720 K and income totals -222,610 K. The company made 243,970 K in profit during its latest quarter, and -23,250 K in sales during its previous quarter.
